Search

Your search keyword '"Levent Kebapcilar"' showing total 14 results
Start Over Author "Levent Kebapcilar" Publisher bioscientifica
14 results on '"Levent Kebapcilar"'

1. Effect of aerobic exercise training on serum malondialdehyde level and quality of life in type 2 diabetes

Author

Sevil Kurban, Mustafa Sait Gonen, Suleyman Hilmi Ipekci, Nesrin Dogan Dede, Levent Kebapcilar, Mihriban Coşkun Arslan, and Mustafa Yildiz

Subjects
chemistry.chemical_compound, medicine.medical_specialty, Quality of life (healthcare), chemistry, business.industry, Physical therapy, Medicine, Aerobic exercise, Type 2 diabetes, business, medicine.disease, Malondialdehyde
Published
2018

3. A rare cause of subclinical hypothyroidism: macro-TSH

Author

Ayse Gul Kebapcilar, Ali Unlu, Sedat Abusoglu, Esra Paydaş Hataysal, Levent Kebapcilar, Cem Onur Kirac, and Suleyman Hilmi Ipekci

Subjects
business.industry, Physiology, Medicine, Macro, business, Subclinical infection
Published
2018

5. A silent thyroiditis in the remission period of Graves' disease

Author

Cem Onur Kirac, Gonca Kara Gedik, Levent Kebapcilar, and Suleyman Hilmi Ipekci

Subjects
Pediatrics, medicine.medical_specialty, business.industry, Period (gene), Graves' disease, Medicine, business, medicine.disease, Thyroiditis
Published
2018

9. High prevalence of lower extremity peripheral artery disease in type 2 diabetes patients with diabetic nephropathy and the role of netrin-1 levels

Author

Levent Kebapcilar, Cem Onur Kirac, Ahmet Kor, Suleyman Baldane, Kamile Marakoğlu, Ali Unlu, Ali Altinok, Bahadir Ozturk, Fatih Çölkesen, and Suleyman Hilmi Ipekci

Subjects
Diabetic nephropathy, medicine.medical_specialty, High prevalence, business.industry, Arterial disease, Internal medicine, Netrin, medicine, Disease, Type 2 diabetes, medicine.disease, business, Gastroenterology
Published
2017

10. Efficacy comparison of oral rosuvastatin versus oral progesterone and bevacizumab on regression of surgically endometriotic implants in rats

Author

Levent Kebapcilar, Ayse Gul Kebapcilar, Duygu Dursunoglu, Mustafa Gazi Uçar, Suleyman Baldane, Kubra Kurt, Cem Onur Kirac, Çetin Çelik, Suleyman Hilmi Ipekci, and Tolgay Tuyan Ilhan

Subjects
medicine.medical_specialty, Bevacizumab, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Intraperitoneal injection, Endometriosis, Drug Evaluation, Preclinical, Urology, Angiogenesis Inhibitors, Pharmacology, 03 medical and health sciences, chemistry.chemical_compound, Glandular epithelium, 0302 clinical medicine, Endocrinology, medicine, Animals, Nandrolone, Rosuvastatin, Rats, Wistar, Rosuvastatin Calcium, 030219 obstetrics & reproductive medicine, business.industry, nutritional and metabolic diseases, Obstetrics and Gynecology, medicine.disease, Surgery, stomatognathic diseases, Dienogest, chemistry, 030220 oncology & carcinogenesis, Female, Hydroxymethylglutaryl-CoA Reductase Inhibitors, business, medicine.drug
Abstract

This study hypothesizes that oral rosuvastatin, oral dienogest and intraperitoneal bevacizumab might improve endometriosis in randomly selected female Wistar albino rats with surgically endometriotic implants. Thirty female Wistar albino rats with surgically endometriotic implants were randomized into three treatment groups: oral rosuvastatin (20 mg kg/day; oral rosuvastatin group 1; n = 10), oral progesterone (dienogest group 2; n = 10) and intraperitoneal bevacizumab (2.5 mg/kg of single intraperitoneal injection of bevacizumab; bevacizumab group 3; n = 10), for 10 days. Post-treatment variables were compared. The oral rosuvastatin group showed higher reduction for the glandular epithelium and uterine vessels of histopathological scores values than the oral progesterone group (both, p 0.017, respectively). The median glandular epithelium and uterine vessels and histopathological scores values did not show a statistically significant difference between group 1 and group 3 (p 0.017). Endometrial thickness values and uterine volume values were more significantly reduced in the oral rosuvastatin group than the oral progesterone group (both, p 0.017, respectively). Moreover, endometrial thickness and uterine volume values were not different in groups wecompared with group 3 (p 0.017). In conclusion, oral rosuvastatin and intraperitoneal injection of bevacizumab may cause more significant regression of surgically endometriotic implants in rats than oral progesterone medications.

Published
2017

Catalog

Books, media, physical & digital resources
See catalog results